Credit Suisse Ag Pliant Therapeutics, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

A detailed history of Credit Suisse Ag transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 65,025 shares of PLRX stock, worth $112,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,025
Previous 61,882 5.08%
Holding current value
$112,493
Previous $1.12 Million 13.57%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$14.14 - $19.59 $44,442 - $61,571
3,143 Added 5.08%
65,025 $968,000
Q4 2023

Feb 08, 2024
BUY
$12.85 - $19.15 $52,967 - $78,936
4,122 Added 7.14%
61,882 $1.12 Million
Q3 2023

Nov 13, 2023
SELL
$14.58 - $20.15 $72,841 - $100,669
-4,996 Reduced 7.96%
57,760 $1 Million
Q2 2023

Aug 11, 2023
BUY
$18.12 - $30.56 $403,731 - $680,907
22,281 Added 55.05%
62,756 $1.14 Million
Q1 2023

May 10, 2023
BUY
$18.73 - $36.26 $131,259 - $254,110
7,008 Added 20.94%
40,475 $1.08 Million
Q4 2022

Feb 13, 2023
BUY
$17.0 - $25.43 $568,939 - $851,065
33,467 New
33,467 $646,000
Q2 2022

Aug 12, 2022
BUY
$4.11 - $8.75 $53 - $113
13 New
13 $0
Q3 2021

Nov 12, 2021
SELL
$16.48 - $28.98 $123,006 - $216,306
-7,464 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$28.05 - $37.69 $20,420 - $27,438
-728 Reduced 8.89%
7,464 $216,000
Q1 2021

May 14, 2021
BUY
$24.52 - $40.23 $200,867 - $329,564
8,192 New
8,192 $322,000

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $84.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email